We are live on
!
Find out more
FA
Friess Associates Portfolio holdings
AUM
$59.9M
1-Year Est. Return
3.42%
This Fund
S&P 500
This Quarter
Est. Return
-13.07%
1 Year Est. Return
+3.42%
3 Year Est. Return
+255.77%
5 Year Est. Return
+639.06%
10 Year Est. Return
–
AUM
$59.9M
AUM Growth
-$128M
(-68%)
Cap. Flow
-$112M
Cap. Flow
% of AUM
-186.73%
Top 10 Holdings %
Top 10 Hldgs %
43.58%
Holding
97
New
8
Increased
2
Reduced
20
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFN
Infinera Corporation Common Stock
INFN
|
+$2.19M |
| 2 |
Caleres
CAL
|
+$2.15M |
| 3 |
Napco Security Technologies
NSSC
|
+$1.81M |
| 4 |
Clearfield
CLFD
|
+$1.39M |
| 5 |
AVX
Avax One Technology Ltd
AVX
|
+$1.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TA
TravelCenters of America LLC
TA
|
+$4.57M |
| 2 |
Adtran
ADTN
|
+$3.71M |
| 3 |
HSII
Heidrick & Struggles
HSII
|
+$3.66M |
| 4 |
Fabrinet
FN
|
+$2.95M |
| 5 |
HUB Group
HUBG
|
+$2.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.49% |
| 2 | Healthcare | 22.03% |
| 3 | Consumer Discretionary | 21.38% |
| 4 | Industrials | 13.44% |
| 5 | Materials | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amphastar Pharmaceuticals
AMPH
$863M
| $3.4M | 5.68% |
97,760
-56,655
| -37% | -$2.02M |
|
2
ACM Research
ACMR
$6.08B
| $3M | 5.01% |
178,368
-149,982
| -46% | -$2.31M |
|
3
Stratasys
SSYS
$711M
| $2.94M | 4.91% |
156,867
-136,379
| -47% | -$2.68M |
|
4
Kura Sushi USA
KRUS
$533M
| $2.83M | 4.73% |
57,237
| – | – |
|
5
DHI Group
DHX
$180M
| $2.4M | 4.01% |
482,884
-53,600
| -10% | -$318K |
|
6
Information Services Group
III
$191M
| $2.36M | 3.94% |
348,781
-316,674
| -48% | -$1.99M |
|
7
Tecnoglass
TGLS
$2.03B
| $2.33M | 3.89% |
132,880
-77,134
| -37% | -$1.64M |
|
8
Titan Machinery
TITN
$444M
| $2.3M | 3.84% |
102,661
+10,161
| +11% | +$253K |
|
|
9
Caleres
CAL
$390M
| $2.28M | 3.81% |
+86,900
| New | +$2.15M |
|
|
ASRT
10
DELISTED
Assertio
ASRT
| $2.26M | 3.78% |
51,110
-28,653
| -36% | -$1.19M |
|
|
DSKE
11
DELISTED
Daseke, Inc. Common Stock
DSKE
| $2.15M | 3.58% |
335,923
-211,422
| -39% | -$1.62M |
|
|
CPRX
12
DELISTED
Catalyst Pharmaceutical
CPRX
| $2.14M | 3.57% |
305,148
-266,792
| -47% | -$1.96M |
|
13
Axogen
AXGN
$2.15B
| $2.08M | 3.47% |
253,546
-168,105
| -40% | -$1.44M |
|
|
14
Napco Security Technologies
NSSC
$1.28B
| $1.98M | 3.3% |
+96,000
| New | +$1.81M |
|
15
Carriage Services
CSV
$584M
| $1.97M | 3.28% |
49,556
-28,000
| -36% | -$1.21M |
|
16
Aehr Test Systems
AEHR
$2.95B
| $1.91M | 3.19% |
255,208
+50,000
| +24% | +$415K |
|
17
MarineMax
HZO
$735M
| $1.88M | 3.13% |
51,904
-34,344
| -40% | -$1.38M |
|
|
INFN
18
DELISTED
Infinera Corporation Common Stock
INFN
| $1.84M | 3.06% |
+342,602
| New | +$2.19M |
|
|
EGIO
19
DELISTED
Edgio, Inc. Common Stock
EGIO
| $1.79M | 2.99% |
19,396
-11,220
| -37% | -$1.61M |
|
20
Ooma
OOMA
$576M
| $1.72M | 2.87% |
145,372
-16,200
| -10% | -$215K |
|
21
Holley
HLLY
$306M
| $1.71M | 2.85% |
162,427
| – | – |
|
22
Bioceres Crop Solutions
BIOX
$21.8M
| $1.66M | 2.77% |
121,129
-48,525
| -29% | -$644K |
|
23
Lantronix
LTRX
$246M
| $1.61M | 2.69% |
299,497
-33,300
| -10% | -$192K |
|
|
24
Clearfield
CLFD
$425M
| $1.46M | 2.44% |
+23,600
| New | +$1.39M |
|
25
InfuSystem Holdings
INFU
$181M
| $1.42M | 2.38% |
147,893
-98,400
| -40% | -$862K |
|
Similar funds
CRCM
BAM
PL
KIP
LCM
IRF
HIH
SM
Friess Associates's Q2 2022 Portfolio in Review
As of Q2 2022, Friess Associates held 97 positions worth $59.9M, down 68% from $187M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Friess Associates withdrew a net $112M in Q2 2022, closing 65 positions and reducing 20 holdings. Its most notable exit was TravelCenters of America LLC, an estimated $4.57M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Friess Associates opened a new position in Infinera Corporation Common Stock worth $1.84M.
- Friess Associates's largest Q2 2022 buy was Infinera Corporation Common Stock: 342,602 shares worth $1.84M.
- Friess Associates added most to Aehr Test Systems in Q2 2022, an estimated $415K increase.
- Friess Associates's biggest Q2 2022 reduction was Stratasys, cutting an estimated $2.68M.
- Friess Associates fully exited TravelCenters of America LLC in Q2 2022, selling an estimated $4.57M.
- Friess Associates's ten largest holdings make up 44% of its $59.9M portfolio in Q2 2022.
- Friess Associates opened 8 new positions and closed 65 in Q2 2022.
- Friess Associates's portfolio value fell 68% quarter-over-quarter to $59.9M.
Based on Friess Associates's 13F filing for Q2 2022, filed 15 Aug 2022.